Cancer & SURVIVEiT News

Category Filter:

Head & Neck: “Study finds combined therapy improves cancer patient results”

August 18, 2020

 Study finds combined therapy improves cancer patient results SIOUX FALLS, S.D., Aug. 11, 2020 — Sanford Health, the largest provider of rural health care in the country, today announced the findings…

Techniques For Targeted Molecular Therapy in Head and Neck Squamous Cell Carcinoma

April 17, 2020

Head and neck squamous cell carcinoma (HNSCC) is the most common type of head and neck cancer. The following is an overview of the techniques used for targeted molecular therapy…

A Head & Neck Cancer Survivor’s Message For Others

April 17, 2020

Everyone’s experience with cancer is unique. The diagnosis, treatment, a patient’s perspective all contribute to a personal story. These factors also play a role in the life a cancer patient…

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma

June 28, 2019

FDA approves pembrolizumab for first-line treatment of head and neck squamous cell carcinoma On June 10, 2019, the Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck) for the first-line treatment…